Visiongain publishes Colon Targeting Drug Delivery Market Report 2020-2030

27 May 2020
Pharma

Visiongain has launched a new report Colon Targeting Drug Delivery Market Report 2020-2030: Forecasts by Approaches (Primary Approaches and Newly Developed Approaches) and by Polymers (Natural Polymers and Synthetic Polymers). PLUS Profiles Of Leading Companies And Regional And Leading National Market Analysis.

The global colon targeting drug delivery market is projected to grow at a CAGR of 8.07% in the first half of the forecast period. Visiongain anticipate that the global market will witness a CAGR of 9.23% during the forecast period 2020 to 2030. The primary approaches for CDDS segment held largest revenue shares of 74.1% in 2019 and is anticipated to witness lucrative growth during the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 238-page Visiongain report provides clear detailed insight into the colon targeting drug delivery market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Colon targeting drug delivery market forecasts from 2020-2030

• This report assesses the colon targeting drug delivery market by approaches and polymers and provides qualitative analysis and forecast of the submarket for the period 2020-2030:

• Approaches:

- Primary Approaches for CDDS
- pH Sensitive Polymer Coated Drug Delivery to the Colon
- Delayed (Time Controlled Release System) Release Drug Delivery to Colon
- Microbially Triggered Drug Delivery to Colon
• Prodrug Approach for Drug Delivery to Colon
• Azo-Polymeric Prodrugs
• Polysaccharide Based Delivery Systems

- Newly Developed Approaches for CDDS categorized into:
- Pressure Controlled Drug-Delivery Systems
- Novel Colon Targeted Delivery System (CODESTM)
- Osmotic Controlled Drug Delivery (ORDS-CT)
- Others

• By Polymers:

- Natural Polymers:
- Pectin
- Guar gum
- Dextran
- Chitosan
- Amylose
- Chondroitin Sulfate
- Inulin
- Cyclodextrin
- Locust bean gum
- Others

- Synthetic Polymers

• Profiles leading companies that will be important in the development of the colon targeting drug delivery market. For each company, developments and outlooks are discussed and companies covered in this chapter include:
• Baxter International Inc.
• 3M Health Care
• Bayer AG
• Boston Scientific Corporation
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Johnson and Johnson
• Novartis AG
• Sanofi SA
• Bausch Health

• Provides qualitative analysis of trends and developments that will affect the colon targeting drug delivery market, from the perspective of pharmaceutical and biotechnology companies, during the period 2020 to 2030.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.

03 December 2020

Read

Visiongain Publishes Drugs of Abuse Testing Market Report 2021-2031

Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

03 December 2020

Read

Visiongain Publishes Controlled Substance Market Report 2021-2031

Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.

03 December 2020

Read

Visiongain Publishes Companion Animal Diagnostics Market Report 2021-2031

All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.

03 December 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever